Zhang-bo Chu

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy and Safety of Amphotericin B Colloidal Dispersion for Patients with Invasive Fungal Disease and Febrile Neutropenia: A Registry-Based, Multicenter, Retrospective, Real-World Study.

Efficacy and Safety of Amphotericin B Colloidal Dispersion for Patients with Invasive Fungal Disease and Febrile Neutropenia: A Registry-Based, Multicenter, Retrospective, Real-World Study.

Journal: Infection and drug resistance

Published: October 08, 2024

Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: a meta-analysis.

Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: a meta-analysis.

Journal: Bioscience reports

Published: March 25, 2017

[Corrigendum] siRNA-mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

[Corrigendum] siRNA-mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

Journal: Oncology reports

Published: September 06, 2016

siRNA-mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

siRNA-mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

Journal: Oncology reports

Published: September 06, 2016

[Retracted] siRNA‑mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

[Retracted] siRNA‑mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.

Journal: Oncology reports

Published: September 06, 2016

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

Journal: Cancer research

Published: February 17, 2015

miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway.

miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway.

Journal: Cancer research

Published: March 07, 2014

Role of brain-derived neurotrophic factor in bone marrow angiogenesis in multiple myeloma.

Role of brain-derived neurotrophic factor in bone marrow angiogenesis in multiple myeloma.

Journal: Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban

Published: December 26, 2012

miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.

miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.

Journal: Carcinogenesis

Published: October 30, 2012

Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo.

Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo.

Journal: International journal of cancer

Published: September 13, 2012

Inhibition of BDNF in multiple myeloma blocks osteoclastogenesis via down-regulated stroma-derived RANKL expression both in vitro and in vivo.

Inhibition of BDNF in multiple myeloma blocks osteoclastogenesis via down-regulated stroma-derived RANKL expression both in vitro and in vivo.

Journal: PloS one

Published: May 29, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026